The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Nuvaxovid heterologous booster
Device/Product Name
Nuvaxovid heterologous booster
Active ingredients
SARS-CoV-2 rS vaccine with Matrix-M1 adjuvant
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-00638-1-2
Submission Type
Major variation (change in dose regimen)
Decision
Approved for provisional registration